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OBJECTIVES We sought to determine: 1) whether normal D-dimer enzyme-linked immunosorbent assay
(ELISA) assays predicted the absence of pulmonary embolism (PE) in the high-volume
emergency department (ED) of the Brigham and Women’s Hospital, and 2) whether ED
physicians accepted normal D-dimer levels as confirmation of no PE without further
diagnostic testing such as lung scanning, chest computed tomography (CT) scanning, or
pulmonary angiography.
BACKGROUND Although the plasma D-dimer ELISA is a sensitive screening test for excluding acute PE, this
laboratory marker has not been widely integrated into clinical algorithms such as creatine
kinase-MB fraction or troponin testing for acute myocardial infarction.
METHODS We mandated that ED physicians order D-dimer ELISA tests on all patients suspected of
acute PE. We reviewed the clinical record of each ED patient initially evaluated for suspected
PE during the year 2000. We determined whether additional imaging tests for PE were
obtained and whether the final diagnosis was PE.
RESULTS Of 1,106 D-dimer assays, 559 were elevated and 547 were normal. Only 2 of 547 had PE
despite a normal D-dimer. The sensitivity of the D-dimer ELISA for acute PE was 96.4%
(95% confidence interval [CI]: 87.5% to 99.6%), and the negative predictive value was 99.6%
(95% CI: 98.7% to 99.9%). Nevertheless, 24% of patients with normal D-dimers had
additional imaging tests for PE.
CONCLUSIONS The D-dimer ELISA has a high negative predictive value for excluding PE. By paying more
attention to normal D-dimer results, fewer chest CT scans and lung scans will be required,
and improvements may be realized in diagnostic efficiency and cost reduction. (J Am Coll
Cardiol 2002;40:1475–8) © 2002 by the American College of Cardiology Foundation
Although the plasma D-dimer enzyme-linked immunosor-
bent assay (ELISA) is a sensitive screening test for exclud-
ing acute pulmonary embolism (PE) (1), this laboratory
marker has not been widely integrated into clinical algo-
rithms such as creatine kinase-MB fraction or troponin
testing for acute myocardial infarction. Accordingly, we
sought to determine: 1) whether normal D-dimer ELISA
assays predicted the absence of PE in the high-volume
emergency department (ED) of the Brigham and Women’s
Hospital, and 2) whether ED physicians accepted normal
D-dimer levels as confirmation of no PE without further
diagnostic testing such as lung scanning, chest computed
tomography (CT) scanning, or pulmonary angiography.
METHODS
We mandated that ED physicians order D-dimer ELISA
tests on all patients suspected of acute PE. We utilized the
VIDAS D-dimer assay (bioMe´rieux; Marcy l’Etoile, France)
(2,3), and our laboratory provided turnaround within 2 h on
a round-the-clock basis. A normal D-dimer to exclude acute
PE was defined as 500 ng/ml. After approval by our
Human Research Committee, we reviewed the clinical
record of each ED patient initially evaluated for suspected
PE during the year 2000. We determined whether addi-
tional imaging tests for PE were obtained and whether the
final diagnosis was PE, as determined by high-probability
lung scan, positive chest CT, or positive pulmonary angio-
gram. Furthermore, we followed up each patient in whom
PE was excluded for the next six months to determine
whether any further imaging tests were ordered and whether
PE was subsequently diagnosed by lung scan, chest CT, or
pulmonary angiography. Our results and recommendations
for patients whom we defined as having no PE were
formulated on the basis of this six-month observation
period.
RESULTS
Overall, 1,106 D-dimer assays were obtained in our ED for
initial evaluation of PE, with 559 abnormally elevated levels
and 547 normal results (Fig. 1). The normal D-dimer group
and the elevated D-dimer group had similar demographic
characteristics (Table 1). Of the 55 patients diagnosed with
acute PE during the initial ED evaluation or six months of
follow-up, 53 presented with elevated D-dimer levels. Only
2 of 547 had PE despite a normal D-dimer (Table 2).
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During six months of follow-up, no additional patients in
the normal D-dimer group (500 ng/ml) were subsequently
diagnosed with PE. Thus, the sensitivity of the D-dimer
ELISA for acute PE was 96.4% (95% confidence interval
[CI]: 87.5% to 99.6%), and the negative predictive value was
99.6% (95% CI: 98.7% to 99.9%). The specificity was
52.0% (95% CI: 48.8% to 54.9%), and the positive predic-
tive value was 9.5% (95% CI: 7.2% to 12.2%).
One of the two patients with false negative D-dimer
results (461 ng/ml) was a 75-year-old woman who was
hospitalized with an exacerbation of chronic obstructive
pulmonary disease. On the second inpatient day, she un-
derwent CT scanning, which demonstrated acute PE. The
other patient was a 26-year-old woman with a history of
recurrent PE who had been noncompliant with anticoagu-
lant therapy prescribed before the ED visit. Her initial
D-dimer was 376 ng/ml, and she was discharged home. She
returned to the ED within 24 h, had a repeat D-dimer of
1,000 ng/ml, and was diagnosed with acute PE by chest
CT scan.
DISCUSSION
Our results indicate that the plasma D-dimer ELISA
confers a high negative predictive value for excluding acute
PE in a large ED cohort of consecutive patients in whom
the diagnosis of PE is suspected. However, despite these
results, our ED physicians pursued the work-up of acute PE
and disregarded the normal D-dimer values in one of every
four patients. This clinical practice resulted in additional
costly testing, radiation exposure, and delay of the disposi-
tion of patients presenting to the ED.
With a high sensitivity, high negative predictive value,
and rapid turnaround time, the D-dimer ELISA functioned
as an excellent screening test for suspected PE. However, as
others have found (4), the D-dimer ELISA was often
elevated in the absence of PE. It had a low specificity and
poor positive predictive value.
Some investigators have had results that differed from
ours. In a study of 198 ED patients, a whole blood assay had
a negative predictive value of only 83% (5). This finding
calls into question whether rapid whole blood D-dimer
assays have adequate sensitivity compared with ELISA
Abbreviations and Acronyms
ED  emergency department
ELISA  enzyme-linked immunosorbent assay
CI  confidence interval
CT  computed tomography
PE  pulmonary embolism
Figure 1. D-dimer results in a series of 1,106 patients evaluated in our emergency department for suspected acute pulmonary embolism.
Table 1. Baseline Characteristics
D-Dimer
< 500 ng/ml
(n  547)
D-Dimer
> 500 ng/ml
(n  559)
Average age  SD (yrs) 43  15 57  18
Male/female 135/412 176/383
No PE imaging 415 209
Any PE imaging 132 350
Lung scan 90 266
CT scan 45 149
Both lung scan and CT scan 6 68
Pulmonary angiogram 9 35
PE diagnosed acutely 2 48
PE diagnosed during subsequent
6 months
0 5
CT  computed tomography; PE  pulmonary embolism.
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when utilized for suspected PE. When a normal whole
blood D-dimer assay result was combined with a normal
bedside alveolar dead-space test, a low prevalence of PE was
accurately predicted (6).
Our findings do not pertain to inpatients suspected of
PE. When D-dimer assays were tested as part of the
diagnostic algorithm among inpatients suspected of PE,
costs increased with D-dimer testing because more patients
with elevated D-dimer results underwent expensive imaging
studies (7). Unfortunately, there was no improvement in
clinical outcomes among patients in the D-dimer group. The
investigators questioned whether D-dimer testing on inpa-
tient services was cost-effective. We note that almost all
studies of plasma D-dimers in the diagnosis of suspected
venous thromboembolism, including ours, have been under-
taken in outpatients, not inpatients (8). The available
evidence indicates that in contrast to outpatients, the
diagnostic strategy of D-dimer measurement appears to be
useless in hospitalized patients (9).
We studied a population of outpatients, many of whom
had no concomitant acute medical problem (which might
elevate D-dimer levels) other than possible PE. Patients for
whom a diagnosis of PE was initially excluded were fol-
lowed for six months to determine if PE was subsequently
diagnosed. Our findings of high sensitivity and high nega-
tive predictive value are strengthened by the large sample
size of 1,106 consecutive patients. Our results are consistent
with those of Perrier et al. (10) who studied 444 consecutive
outpatients with suspected PE. However, our results cannot
necessarily be generalized to other ELISA assays of D-dimer
because each assay has a different sensitivity and negative
predictive value for acute PE (11).
A cautionary note is appropriate because almost all
diagnoses of PE in this study were established or excluded
on the basis of noninvasive testing. It is important to
recognize and acknowledge the vagaries and limitations of
noninvasive testing for suspected PE. Criteria for interpret-
ing lung scans are complicated (12), and lung scanning,
unlike chest CT, does not provide adequate confirmation or
exclusion of PE in the majority of patients who undergo this
test (13). Among unselected outpatients with suspected PE,
as many as 30% of the emboli may escape detection on
first-generation single-slice CT scanners (14). New, multi-
slice scanners increase imaging speed and allow improve-
ment in resolution from 5 mm to 1 mm (15). In the short
time that has elapsed since completion of our ED study in
which lung scanning was used almost twice as frequently as
chest CT scanning, CT has now overtaken lung scanning as
the primary noninvasive imaging modality for suspected PE
(16,17). However, despite the limitations of noninvasive
testing, an integrated diagnostic strategy has been validated
in which very few patients ultimately require pulmonary
angiography (18). Therefore, we believe that our sensitivity
and specificity analyses for the VIDAS D-dimer ELISA are
valid in the ED population that we describe.
Our findings indicate that a negative VIDAS D-dimer
ELISA can almost always exclude acute PE in the ED
setting. Furthermore, additional opportunities exist for ed-
ucational initiatives on the role of the D-dimer ELISA in
the evaluation of possible PE. Dual intervention with
intensified teaching and more rigidly enforced diagnostic
algorithms may yield improvements in efficiency and cost
reduction.
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